Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients

Axillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the...

Descripción completa

Detalles Bibliográficos
Autores: Acea Nebril, Benigno, García Novoa, Alejandra, Bouzón Alejandro, Alberto, Diaz Carballada, Carlota Czestokowa, Conde Iglesias, Carmen
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/21819
Acceso en línea:https://portalcientifico.sergas.gal//documentos/6550da4892517a5a7db95402
http://hdl.handle.net/20.500.11940/21819
Access Level:acceso abierto
Palabra clave:Humans
Female
Neoadjuvant Therapy
Iodine Radioisotopes
Breast Neoplasms
Neoplasm Staging
Thyroid Neoplasms
Lymph Nodes
Sentinel Lymph Node
Sentinel Lymph Node Biopsy
Lymph Node Excision
Lymphadenopathy
Axilla
AS A Coruña
INIBIC
CHUAC
Descripción
Sumario:Axillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the axillary staging method during surgery remains controversial. There are at least three validated methods: SLNB, targeted axillary dissection (TAD) and marking axillary nodes with radioactive iodine seeds (MARI) procedure. Our house believe that the biopsied and clipped lymph node could predict response to systemic treatment.